Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 202
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04824339 | Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial. | ||
| NCT01046123 | Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases | ||
| NCT01120470 | OGX-427 in Castration Resistant Prostate Cancer Patients | ||
| NCT00538772 | An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy | ||
| NCT07621146 | A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies | ||
| NCT03769103 | Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC | ||
| NCT01384890 | Feasibility of VMAT and CBCT for Head and Neck Carcinomas | ||
| NCT02899312 | PSMA PET/CT for Assessment of Recurrent Prostate Cancer | ||
| NCT05786599 | Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy | ||
| NCT00070083 | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | ||
| NCT01630967 | Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) | ||
| NCT02254785 | Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer | ||
| NCT03948074 | Cannabis For Cancer-Related Symptoms | ||
| NCT05576831 | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | ||
| NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | ||
| NCT07291895 | High Dose Radiotherapy for Palliation (Hi-D) | ||
| NCT03202810 | Innovative Approach to Triage Oral Precancer | ||
| NCT02431715 | 18F-FDOPA PET in Neuroendocrine Tumours | ||
| NCT03364621 | Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy | ||
| NCT04610372 | 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | ||
| NCT06726642 | CfDNA in Hereditary And High-risk Malignancies 2 | ||
| NCT02627703 | (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer | ||
| NCT03694015 | SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases | ||
| NCT01446991 | Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy | ||
| NCT00800189 | Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) | ||
| NCT02484131 | Bone Health Management for Women Diagnosed With Breast Cancer | ||
| NCT05784428 | Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression | ||
| NCT01604759 | Polarized Reflectance Spectroscopy for Oral Lesions | ||
| NCT01936883 | Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy | ||
| NCT02796729 | CEST- Glucose Enhanced MRI for Metastatic Brain Tumours | ||
| NCT00911456 | Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy | ||
| NCT02220491 | Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases | ||
| NCT04831307 | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical | ||
| NCT02869802 | Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | ||
| NCT01811602 | Gynecological Pelvic Floor Muscle Training | ||
| NCT00629577 | Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples | ||
| NCT00757692 | Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. | ||
| NCT03031821 | Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome | ||
| NCT06915779 | Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | ||
| NCT00632190 | Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy | ||
| NCT03246802 | Partial Prostate Salvage High Dose Rate Brachytherapy | ||
| NCT01089699 | A Trial Testing Professional and Peer-led Support Online Support Groups for Young Canadian Breast Cancer Survivors | ||
| NCT05057234 | PRecision Oncology Evidence Development in Cancer Treatment - Liquid | ||
| NCT06650709 | NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study | ||
| NCT01719068 | Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos | ||
| NCT03450018 | A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX | ||
| NCT00522197 | ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia | ||
| NCT06208735 | CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies | ||
| NCT00473083 | Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer | ||
| NCT04185389 | Long-Term Follow-Up of HPV FOCAL Participants |
